260 related articles for article (PubMed ID: 16366042)
1. Mechanisms involved in the anti-inflammatory effect of a standardized willow bark extract.
Khayyal MT; El-Ghazaly MA; Abdallah DM; Okpanyi SN; Kelber O; Weiser D
Arzneimittelforschung; 2005; 55(11):677-87. PubMed ID: 16366042
[TBL] [Abstract][Full Text] [Related]
2. In vitro anti-proliferative effects of the willow bark extract STW 33-I.
Bonaterra GA; Kelber O; Weiser D; Metz J; Kinscherf R
Arzneimittelforschung; 2010; 60(6):330-5. PubMed ID: 20648923
[TBL] [Abstract][Full Text] [Related]
3. Nitric oxide (NO)-releasing naproxen (HCT-3012 [(S)-6-methoxy-alpha-methyl-2-naphthaleneacetic Acid 4-(nitrooxy)butyl ester]) interactions with aspirin in gastric mucosa of arthritic rats reveal a role for aspirin-triggered lipoxin, prostaglandins, and NO in gastric protection.
Fiorucci S; Di Lorenzo A; Renga B; Farneti S; Morelli A; Cirino G
J Pharmacol Exp Ther; 2004 Dec; 311(3):1264-71. PubMed ID: 15297470
[TBL] [Abstract][Full Text] [Related]
4. Amelioration of collagen-induced arthritis by Salix nigra bark extract via suppression of pro-inflammatory cytokines and oxidative stress.
Sharma S; Sahu D; Das HR; Sharma D
Food Chem Toxicol; 2011 Dec; 49(12):3395-406. PubMed ID: 21983485
[TBL] [Abstract][Full Text] [Related]
5. Anti-inflammatory effects of the willow bark extract STW 33-I (Proaktiv(®)) in LPS-activated human monocytes and differentiated macrophages.
Bonaterra GA; Heinrich EU; Kelber O; Weiser D; Metz J; Kinscherf R
Phytomedicine; 2010 Dec; 17(14):1106-13. PubMed ID: 20570123
[TBL] [Abstract][Full Text] [Related]
6. Nitric oxide (NO)-releasing aspirin exhibits a potent esophagoprotection in experimental model of acute reflux esophagitis. Role of nitric oxide and proinflammatory cytokines.
Pawlik M; Pajdo R; Kwiecien S; Ptak-Belowska A; Sliwowski Z; Mazurkiewicz-Janik M; Konturek SJ; Pawlik WW; Brzozowski T
J Physiol Pharmacol; 2011 Feb; 62(1):75-86. PubMed ID: 21451212
[TBL] [Abstract][Full Text] [Related]
7. Antibiotic treatment with ampicillin accelerates the healing of colonic damage impaired by aspirin and coxib in the experimental colitis. Importance of intestinal bacteria, colonic microcirculation and proinflammatory cytokines.
Zwolinska-Wcislo M; Krzysiek-Maczka G; Ptak-Belowska A; Karczewska E; Pajdo R; Sliwowski Z; Urbanczyk K; Drozdowicz D; Konturek SJ; Pawlik WW; Brzozowski T
J Physiol Pharmacol; 2011 Jun; 62(3):357-68. PubMed ID: 21893697
[TBL] [Abstract][Full Text] [Related]
8. Willow species and aspirin: different mechanism of actions.
Vlachojannis J; Magora F; Chrubasik S
Phytother Res; 2011 Jul; 25(7):1102-4. PubMed ID: 21226125
[TBL] [Abstract][Full Text] [Related]
9. Renal functional responses to ischaemia-reperfusion injury in normotensive and hypertensive rats following non-selective and selective cyclo-oxygenase inhibition with nitric oxide donation.
Knight S; Johns EJ
Clin Exp Pharmacol Physiol; 2008 Jan; 35(1):11-6. PubMed ID: 18047621
[TBL] [Abstract][Full Text] [Related]
10. Chemopreventive properties of a selective inducible nitric oxide synthase inhibitor in colon carcinogenesis, administered alone or in combination with celecoxib, a selective cyclooxygenase-2 inhibitor.
Rao CV; Indranie C; Simi B; Manning PT; Connor JR; Reddy BS
Cancer Res; 2002 Jan; 62(1):165-70. PubMed ID: 11782374
[TBL] [Abstract][Full Text] [Related]
11. Biochemical and pharmacological profile of a tetrasubstituted furanone as a highly selective COX-2 inhibitor.
Riendeau D; Percival MD; Boyce S; Brideau C; Charleson S; Cromlish W; Ethier D; Evans J; Falgueyret JP; Ford-Hutchinson AW; Gordon R; Greig G; Gresser M; Guay J; Kargman S; Léger S; Mancini JA; O'Neill G; Ouellet M; Rodger IW; Thérien M; Wang Z; Webb JK; Wong E; Chan CC
Br J Pharmacol; 1997 May; 121(1):105-17. PubMed ID: 9146894
[TBL] [Abstract][Full Text] [Related]
12. Contribution of flavonoids and catechol to the reduction of ICAM-1 expression in endothelial cells by a standardised Willow bark extract.
Freischmidt A; Jürgenliemk G; Kraus B; Okpanyi SN; Müller J; Kelber O; Weiser D; Heilmann J
Phytomedicine; 2012 Feb; 19(3-4):245-52. PubMed ID: 21982436
[TBL] [Abstract][Full Text] [Related]
13. Novel neurological and immunological targets for salicylate-based phytopharmaceuticals and for the anti-depressant imipramine.
Ulrich-Merzenich G; Kelber O; Koptina A; Freischmidt A; Heilmann J; Müller J; Zeitler H; Seidel MF; Ludwig M; Heinrich EU; Winterhoff H
Phytomedicine; 2012 Jul; 19(10):930-9. PubMed ID: 22743246
[TBL] [Abstract][Full Text] [Related]
14. Valdecoxib: assessment of cyclooxygenase-2 potency and selectivity.
Gierse JK; Zhang Y; Hood WF; Walker MC; Trigg JS; Maziasz TJ; Koboldt CM; Muhammad JL; Zweifel BS; Masferrer JL; Isakson PC; Seibert K
J Pharmacol Exp Ther; 2005 Mar; 312(3):1206-12. PubMed ID: 15494548
[TBL] [Abstract][Full Text] [Related]
15. Lysosomal membrane stabilization and anti-inflammatory activity of Clerodendrum phlomidis L.f., a traditional medicinal plant.
Babu NP; Pandikumar P; Ignacimuthu S
J Ethnopharmacol; 2011 Jun; 135(3):779-85. PubMed ID: 21527330
[TBL] [Abstract][Full Text] [Related]
16. Preclinical pharmacology profile of CS-706, a novel cyclooxygenase-2 selective inhibitor, with potent antinociceptive and anti-inflammatory effects.
Ushiyama S; Yamada T; Murakami Y; Kumakura S; Inoue S; Suzuki K; Nakao A; Kawara A; Kimura T
Eur J Pharmacol; 2008 Jan; 578(1):76-86. PubMed ID: 17920584
[TBL] [Abstract][Full Text] [Related]
17. Wound collagen deposition in rats: effects of an NO-NSAID and a selective COX-2 inhibitor.
Muscará MN; McKnight W; Asfaha S; Wallace JL
Br J Pharmacol; 2000 Feb; 129(4):681-6. PubMed ID: 10683192
[TBL] [Abstract][Full Text] [Related]
18. Healing of chronic gastric ulcers in diabetic rats treated with native aspirin, nitric oxide (NO)-derivative of aspirin and cyclooxygenase (COX)-2 inhibitor.
Brzozowska I; Targosz A; Sliwowski Z; Kwiecien S; Drozdowicz D; Pajdo R; Konturek PC; Brzozowski T; Pawlik M; Konturek SJ; Pawlik WW; Hahn EG
J Physiol Pharmacol; 2004 Dec; 55(4):773-90. PubMed ID: 15613743
[TBL] [Abstract][Full Text] [Related]
19. Comparative Anti-Inflammatory Effects of
Le NPK; Herz C; Gomes JVD; Förster N; Antoniadou K; Mittermeier-Kleßinger VK; Mewis I; Dawid C; Ulrichs C; Lamy E
Int J Mol Sci; 2021 Jun; 22(13):. PubMed ID: 34201817
[TBL] [Abstract][Full Text] [Related]
20. Pharmacological profile of celecoxib, a specific cyclooxygenase-2 inhibitor.
Yoshino T; Kimoto A; Kobayashi S; Noguchi M; Fukunaga M; Hayashi A; Miyata K; Sasamata M
Arzneimittelforschung; 2005; 55(7):394-402. PubMed ID: 16080279
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
